Shenzhen Stock Exchange: From July 13 to July 17, 2026, the firm adopted self-regulatory measures on a total of 173 cases of abnormal securities transactions, involving abnormal trading situations such as intraday suppression and false declarations; carried out key monitoring of “Wanbang Pharmaceutical”, which recently had serious abnormal stock price fluctuations; verified 19 important matters of listed companies and reported 4 suspected cases of illegal violations to the Securities Regulatory Commission.

Shenzhen Stock Exchange: From July 13 to July 17, 2026, the firm adopted self-regulatory measures on a total of 173 cases of abnormal securities transactions, involving abnormal trading situations such as intraday suppression and false declarations; carried out key monitoring of “Wanbang Pharmaceutical”, which recently had serious abnormal stock price fluctuations; verified 19 important matters of listed companies and reported 4 suspected cases of illegal violations to the Securities Regulatory Commission.